Predictors of Location of Death for Children with Cancer Enrolled on a Palliative Care Service

Background In the U.S., more children die from cancer than from any other disease, and more than one third die in the hospital setting. These data have been replicated even in subpopulations of children with cancer enrolled on a palliative care service. Children with cancer who die in high‐acuity in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The oncologist (Dayton, Ohio) Ohio), 2018-12, Vol.23 (12), p.1525-1532
Hauptverfasser: Kaye, Erica C., DeMarsh, Samantha, Gushue, Courtney A., Jerkins, Jonathan, Sykes, April, Lu, Zhaohua, Snaman, Jennifer M., Blazin, Lindsay J., Johnson, Liza‐Marie, Levine, Deena R., Morrison, R. Ray, Baker, Justin N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background In the U.S., more children die from cancer than from any other disease, and more than one third die in the hospital setting. These data have been replicated even in subpopulations of children with cancer enrolled on a palliative care service. Children with cancer who die in high‐acuity inpatient settings often experience suffering at the end of life, with increased psychosocial morbidities seen in their bereaved parents. Strategies to preemptively identify children with cancer who are more likely to die in high‐acuity inpatient settings have not been explored. Materials and Methods A standardized tool was used to gather demographic, disease, treatment, and end‐of‐life variables for 321 pediatric palliative oncology (PPO) patients treated at an academic pediatric cancer center who died between 2011 and 2015. Multinomial logistic regression was used to predict patient subgroups at increased risk for pediatric intensive care unit (PICU) death. Results Higher odds of dying in the PICU were found in patients with Hispanic ethnicity (odds ratio [OR], 4.02; p = .002), hematologic malignancy (OR, 7.42; p 
ISSN:1083-7159
1549-490X
DOI:10.1634/theoncologist.2017-0650